VEON's EBITDA for 8 months of 2022 was $2.29bn, up 3.9% from $2.205bn in the previous year. Revenue increased by 3.1% to $5.226bn compared to $5.07bn a year earlier. Also the company announced the purchase of the controlling stake of Kyivstar Helsi, which develops SaaS solutions for medical information systems. Helsi solutions are used by 1,600 healthcare institutions across Ukraine.